Hjem › Overvægt › Arizona › Tucson
Overvægt kliniske forsøg i Tucson, AZ
17 studier for Overvægt søger deltagere på steder i og omkring Tucson (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RekruttererFase 3
- University of Arizona, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RekruttererFase 3
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruttererFase 3
- Research Site, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RekruttererFase 3
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekruttererFase 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 3
- AURORA-1 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Tucson
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruttererFase 3
- Pima Heart and Vascular Clinical Research, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RekruttererFase 3
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RekruttererFase 3
- Arizona Clinical Trials, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RekruttererFase 3Frivillige med god helbredstilstand velkomne
- ACCOMPLISH-2 Research Site, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekruttererFase 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RekruttererFase 2
- Pima Heart, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RekruttererFase 3
- ACCOMPLISH-1 Research Site, Tucson
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
RekruttererFase 1/2
- Adobe Clinical Research, Tucson
Overvægt forsøg i andre byer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Las Vegas, NV27 studier
- Miami, FL27 studier
- Baltimore, MD25 studier
- Jacksonville, FL25 studier
Andre studier i Tucson
- Brystkræft20 studier
- Ikke-småcellet lungecancer17 studier
- Overvægt15 studier
- Metastatisk cancer14 studier
- Kræft (alle typer)12 studier
- Kardiovaskulær sygdom12 studier
- Colorektal kræft11 studier
- Prostatakræft11 studier
- Steatotisk leversygdom10 studier
- Hjertesvigt10 studier
- Højt blodtryk10 studier
- Type 2-diabetes10 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.